Question 1

What is the catalog number for 4- (4-Chloro-phenylsulfamoyl) -benzoic acid?

Accepted Answer

The catalog number for 4- (4-Chloro-phenylsulfamoyl) -benzoic acid is sc-347981.

Question 2

What sizes are available for 4- (4-Chloro-phenylsulfamoyl) -benzoic acid?

Accepted Answer

4- (4-Chloro-phenylsulfamoyl) -benzoic acid is available in the following size(s): 1 g.

Question 3

Is 4- (4-Chloro-phenylsulfamoyl) -benzoic acid in stock?

Accepted Answer

4- (4-Chloro-phenylsulfamoyl) -benzoic acid is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 5

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 6

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

4- (4-Chloro-phenylsulfamoyl) -benzoic acid

Product Specifications

Frequently Asked Questions

Explore Other Products

Erythropoietin (EPO) (Marker of Placentation Disorders) (EPO/3793R), CF405S conjugate, 0.1mg/mL

CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (LPFS2/2034R), CF568 conjugate, 0.1mg/mL

Thymidylate Synthase (5-FU Resistance Marker) (TYMS/1884), CF405S conjugate, 0.1mg/mL

B7-H4 (Immuno-Inhibitory Protein) (B7H4/1788), CF405S conjugate, 0.1mg/mL

Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/2571R), CF594 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL